Diagnosing PCVAD in Practice: From Clinical Suspicion to Laboratory Confirmation

Porcine Circovirus-Associated Disease (PCVAD) can present with a wide range of clinical signs, making diagnosis challenging in field conditions. Weight loss, poor growth, respiratory problems, diarrhea, pallor, and wasting may indicate PCV2 involvement, but these findings are not specific and can occur with several other infectious and management-related conditions. Therefore, accurate diagnosis requires a combination of clinical evaluation, pathological assessment, and laboratory confirmation. 

For practicing veterinarians, the objective is not only to detect PCV2 but also to determine whether PCV2 is contributing to the observed disease process within the herd. A structured diagnostic approach helps differentiate PCVAD from other conditions with similar clinical presentations. 

Clinical Evaluation: Recognizing Suspicious Cases 

The first step in PCVAD diagnosis is careful evaluation of clinical signs and herd history. Affected pigs may show progressive weight loss, poor growth performance, generalized wasting, and reduced vitality. Respiratory signs such as coughing and labored breathing may occur, along with gastrointestinal signs including diarrhea, which may appear dark and tarry due to intestinal bleeding¹. 

However, clinical signs alone cannot confirm PCVAD. Confirmation requires identification of PCV2-associated lesions and detection of viral antigen or nucleic acid in appropriate tissues. Samples from lymphoid organs, along with affected non-lymphoid tissues such as lungs, liver, kidneys, or intestines, may provide valuable diagnostic information². 

Histopathology and Immunohistochemistry: Linking Virus with Lesions 

Histopathology remains a key component of PCVAD diagnosis because disease development is closely associated with characteristic tissue changes. Important microscopic findings include: 

• Lymphoid depletion 

• Granulomatous inflammation 

• Presence of inclusion bodies within histiocytes and other cells 

• Syncytial cells within lymphoid tissues 

Lymph nodes, Peyer’s patches, and intestinal lamina propria are commonly affected tissues where these changes may be identified³. 

Immunohistochemistry (IHC) and in situ hybridization (ISH) are recognized as gold-standard methods for detecting PCV2 within tissue sections. IHC uses antibodies targeting PCV2 antigens and provides visual confirmation of viral distribution within cells. ISH detects viral nucleic acids within tissues, allowing precise localization, although it generally requires more time and resources compared with IHC³. 

The combination of PCV2 detection with significant tissue lesions provides stronger evidence of PCVAD involvement than viral detection alone. 

PCR and Quantitative PCR for PCV2 Detection 

Polymerase Chain Reaction (PCR) provides rapid detection of PCV2 DNA from samples such as blood, serum, and tissues. It is particularly useful when evaluating live animals suspected of PCV2 infection. 

Advanced PCR-based methods can also support genotype identification. PCR-REBA (Reverse Blot Hybridization Assay) and multiplex real-time PCR allow detection and differentiation of PCV2 genotypes within clinical samples⁴. 

TaqMan-based quantitative PCR (qPCR) assays provide accurate estimation of viral load and have demonstrated high sensitivity and specificity for PCV2 detection⁵. Digital droplet PCR (ddPCR) has further improved detection capabilities, particularly when viral quantities are low, by enabling highly sensitive viral quantification⁶. 

Serological Testing and Genotype Differentiation 

Serological methods such as Immunofluorescence Assay (IFA), Immunoperoxidase Monolayer Assay (IPMA), and Enzyme-Linked Immunosorbent Assay (ELISA) are useful for monitoring PCV2 antibody responses. 

ELISA interpretation depends on antibody patterns. Higher IgM levels compared with IgG may indicate an early active infection, while an IgG-dominant response may suggest later-stage infection or previous exposure². 

Genotype differentiation is also important for understanding PCV2 circulation within herds. ORF2-based PCR-RFLP assays, high-resolution melting analysis (HRMA), and next-generation sequencing (NGS) provide tools for identifying genetic variation among PCV2 strains⁷. 

Practical Clinical Insights 

For field diagnosis of PCVAD, veterinarians should focus on: 

• Combining clinical findings with pathological lesions rather than relying on a single diagnostic test. 

• Selecting appropriate tissues, especially lymphoid organs, when submitting samples. 

• Interpreting PCV2 detection alongside lesion severity and clinical presentation. 

• Considering co-infections when clinical signs are more severe than expected. 

A comprehensive diagnostic approach allows veterinarians to accurately assess the role of PCV2 in herd health problems and supports informed decisions for disease management and prevention. 

References 

1. Maity HK, Samanta K, Deb R, Gupta VK. Revisiting porcine circovirus infection: recent insights and its significance in the piggery sector. Vaccines. 2023 Jul 31;11(8):1308. https://www.mdpi.com/2076-393X/11/8/1308 

2. Opriessnig T, Karuppannan AK, Castro AM, Xiao CT. Porcine circoviruses: current status, knowledge gaps and challenges. Virus research. 2020 Sep 1;286:198044. https://doi.org/10.1016/j.virusres.2020.198044 

3. Borah D, Hazarika R, Hazarika G, Saikia DP, Mili P, Bappu HP, Islam I, Barua J, Brahma D, George S. Porcine circovirus diseases: current insights and future strategies for effective Control, with a focus on Porcine circovirus 2 (PCV2). Microbiol Res J Int. 2024 Dec 30;34(12):283-98. https://www.researchgate.net/publication/387723361 

4. Ke CH, Du MY, Hsieh WJ, Lin CC, Ting JM, Chiou MT, Lin CN. Implementation of point-of-care platforms for rapid detection of porcine circovirus type 2. Journal of veterinary science. 2024 Mar 11;25(2):e28. https://pmc.ncbi.nlm.nih.gov/articles/PMC10990909/pdf/jvs-25-e28.pdf 

5. Henriques AM, Duarte M, Barros SC, Fagulha T, Ramos F, Luís T, Fevereiro M. Development and validation of a real-time PCR for the detection and quantification of porcine circovirus type 2. Virusdisease. 2018 Sep;29(3):355-61. https://pmc.ncbi.nlm.nih.gov/articles/PMC6111954/ 

6. Mu Y, Jia C, Zheng X, Zhu H, Zhang X, Xu H, Liu B, Zhao Q, Zhou EM. A nanobody‐horseradish peroxidase fusion protein‐based competitive ELISA for rapid detection of antibodies against porcine circovirus type 2. Journal of Nanobiotechnology. 2021 Feb 1;19(1):34. https://link.springer.com/content/pdf/10.1186/s12951-021-00778-8.pdf 

7. Franzo G, Tucciarone CM, Legnardi M, Drigo M, Segalés J. An updated phylogeography and population dynamics of porcine circovirus 2 genotypes: are they reaching an equilibrium?. Frontiers in microbiology. 2024 Oct 29;15:1500498. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2024.1500498/pdf